Market Access

W2O hires Edelman's Rita Glaze to lead value, pricing, market access practice

W2O hires Edelman's Rita Glaze to lead value, pricing, market access practice

By

Glaze worked in Edelman's market access practice for more than seven years.

Mitsubishi Tanabe's Kevin O'Brien on driving unmet needs

Mitsubishi Tanabe's Kevin O'Brien on driving unmet needs

By

The VP of market access at Mitsubishi Tanabe Pharma America discusses driving access and bringing to market the first FDA-approved ALS drug in years.

Speaker bureaus must change to stay relevant, experts say

Speaker bureaus must change to stay relevant, experts say

By

To remain relevant, speakers bureaus must evolve to a strategic marketing tactic with personalized messaging to the customer.

Infographic | The leaders of the global hepatitis-C market

Infographic | The leaders of the global hepatitis-C market

By

Despite approvals of competing products from AbbVie, Merck, and Bristol-Myers Squibb, Gilead remains the market leader.

Roundtable: Market access takes center stage

Roundtable: Market access takes center stage

By

Participants in this roundtable explore how digital forms of data are poised to illuminate the reimbursement pathway, as market access gets its closeup.

Intouch Solutions' Weissberg on the rising payer voice

Intouch Solutions' Weissberg on the rising payer voice

By

The group director of Intouch Solutions' newly launched market access business is betting that the payer will gain in influence.

Medicines360 CEO battles for IUD access

Medicines360 CEO battles for IUD access

By

Prior to Medicines360's arrival on the scene, there were only three IUDs on the market. The lack of competition drove prices sky-high.

Market Access: Looking Back, Looking Ahead

Market Access: Looking Back, Looking Ahead

Securing market access has become significantly more challenging for pharma marketers.